Monte Rosa Therapeutics, Inc. SEC filings GLUE
Monte Rosa Therapeutics, Inc. has 401 filings in SEC EDGAR's recent list, going back to Sep 29, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 15, 2026 |
| 144 | Notice of proposed sale | Jul 16, 2026 | — |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 4 | Insider transaction | Jul 7, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 6, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 4 | Insider transaction | Jun 30, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 29, 2026 |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 25, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 23, 2026 |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 144 | Notice of proposed sale | Jun 17, 2026 | — |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 1, 2026 |
| 144/A | Filing | Jun 2, 2026 | — |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 144 | Notice of proposed sale | May 29, 2026 | — |
| 4 | Insider transaction | May 28, 2026 | May 27, 2026 |
| 144 | Notice of proposed sale | May 27, 2026 | — |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 144 | Notice of proposed sale | May 22, 2026 | — |
| 144 | Notice of proposed sale | May 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 22, 2026 | — |
| 144 | Notice of proposed sale | Apr 16, 2026 | — |
| 4 | Insider transaction | Apr 15, 2026 | Apr 14, 2026 |
| 144 | Notice of proposed sale | Apr 14, 2026 | — |
| 144 | Notice of proposed sale | Apr 13, 2026 | — |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 144 | Notice of proposed sale | Apr 8, 2026 | — |
| 4 | Insider transaction | Apr 7, 2026 | Apr 6, 2026 |
| 3 | Initial insider ownership | Apr 7, 2026 | Apr 3, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Mar 17, 2026 | — |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Feb 27, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 11, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 10, 2026 | Feb 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jan 9, 2026 | Jan 8, 2026 |
| 424B5 | Prospectus supplement | Jan 9, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 9, 2026 | — |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 144/A | Filing | Jan 8, 2026 | — |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2025 | Dec 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 31, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 3, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 15, 2025 | Sep 15, 2025 |
| UPLOAD | Letter from the SEC | Aug 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 6, 2025 | — |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 16, 2025 | — |
| EFFECT | Filing | Mar 31, 2025 | — |
| CORRESP | Letter to the SEC | Mar 27, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2025 | — |
| 4 | Insider transaction | Mar 25, 2025 | Mar 24, 2025 |
| S-3 | Shelf registration | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 20, 2025 | Mar 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 31, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 30, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 11, 2024 |
| 3 | Initial insider ownership | Dec 13, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2024 | Dec 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 30, 2024 | — |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 144 | Notice of proposed sale | Oct 28, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 28, 2024 | Oct 25, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 24, 2024 | — |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 13, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 12, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 12, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Jul 9, 2024 | Jul 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 3 | Initial insider ownership | Jun 5, 2024 | May 28, 2024 |
| 3 | Initial insider ownership | Jun 5, 2024 | May 28, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 30, 2024 | May 28, 2024 |
| 8-K |
Current report
Material agreement
|
May 16, 2024 | May 15, 2024 |
| 424B5 | Prospectus supplement | May 16, 2024 | — |
| 424B5 | Prospectus supplement | May 15, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 13, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GLUE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1826457
- Former names
- Monte Rosa Therapeutics, Inc. (until Nov 5, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.